Renue By Science GABA | High Strength Liposomal GABA Supplements | 90 GABA Capsules - 300mg Gamma-Aminobutyric Acid per Serving | Non-GMO | Made in The USA Third-Party Tested
- NERVOUS SYSTEM SUPPORT - GABA, the main inhibitory neurotransmitter in your brain, acts as a natural "brake" on the nervous system, helping to maintain a sense of calm and relaxation.*
- MOOD AND SLEEP BALANCE - LIPO GABA is designed to balance mood, promote restful sleep, and support overall well-being by settling the mind and managing your response to stress.*
- ENHANCED BIOAVAILABILITY - Our advanced liposomal delivery system improves the bioavailability of GABA, ensuring better absorption and a slower release into the bloodstream for maximum efficacy.*
- RAPID ABSORPTION - GABA is absorbed quickly, with levels in the blood shown to decline 30 minutes after administration, making our liposomal delivery system crucial for optimal benefits.*
- QUALITY AND SAFETY ASSURED - GABA (Liposomal) 90 Ct. is allergen-free, manufactured in a GMP compliant, FDA registered facility, and undergoes rigorous third-party testing to ensure the highest quality standards for your well-being.
Informazio garrantzitsua
Osagaiak
Gamma-Aminobutyric Acid
Lege oharra
FDAk ez ditu ebaluatu dieta-gehigarriei buruzko instrukzioak, eta ez dute diagnostikatu, tratatu, sendatu edo gaixotasun edo osasun-egoera saihesteko asmorik.
Paketeen neurriak
4.41 x 2.2 x 1.81 inches; 3.17 ounces
Specifications
| Brand | Zientziaren aldaketa |
| Iraungitze-data | 2027ko urtarrila |
| Flavor | Flavor |
| Unitate kopurua | 90.00 |
| Elementuaren forma | Kapsulatu |
| Adin tartea (azalpena) | Heldua |
| Elementu kopurua | 1 |
| Edukiontzi bakoitzeko zerbitzuak | 9 |
| Dosage formularioa | Kapsulatu |
| Formatua | Botila |
| Materialaren ezaugarria | Naturala |
| Produktu mota | Nutrizio gehigarria |
| Osagaiak | Gamma |
| Tags | |
|---|---|
| Tags | |
Your Dynamic Snippet will be displayed here...
This message is displayed because youy did not provide both a filter and a template to use.







